Skip to main content

Rosenberg Ellen's Form 4 filing

Amicus Therapeutics, Inc. (FOLD) · filed Dec 28, 2023

Accession no.
0000950170-23-073627
Filed
Dec 28, 2023
Trade date
Dec 26-27, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $490.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rosenberg EllenCIK 0001666380Officer (Chief Legal Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 26, 2023Common StockMOption exerciseAcquired+30,000$5.16+$154,800372,285Direct
Dec 26, 2023Common StockSSaleDisposed−30,000$14.00−$420,000342,285Direct
Dec 27, 2023Common StockMOption exerciseAcquired+5,000$5.16+$25,800347,285Direct
Dec 27, 2023Common StockSSaleDisposed−5,000$14.07−$70,350342,285Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 26, 2023Common StockMOption exerciseDisposed−30,000$0.00$065,000Direct
Dec 27, 2023Common StockMOption exerciseDisposed−5,000$0.00$060,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)